Clinical Trial Update: Study in Subjects With Moderate Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a treatment in subjects with moderate atopic dermatitis (eczema).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: Ralexar Therapeutics, Inc. | Conditions: Atopic Dermatitis Eczema | Phase 2 | Status: UNKNOWN